These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 20578153)

  • 1. Fitness versus fatness: moving beyond weight loss in nonalcoholic fatty liver disease.
    Johnson NA; George J
    Hepatology; 2010 Jul; 52(1):370-81. PubMed ID: 20578153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-alcoholic fatty liver disease.
    Kantartzis K; Thamer C; Peter A; Machann J; Schick F; Schraml C; Königsrainer A; Königsrainer I; Kröber S; Niess A; Fritsche A; Häring HU; Stefan N
    Gut; 2009 Sep; 58(9):1281-8. PubMed ID: 19074179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of body weight, diet and lifestyle on nonalcoholic fatty liver disease.
    Cortez-Pinto H; Machado M
    Expert Rev Gastroenterol Hepatol; 2008 Apr; 2(2):217-31. PubMed ID: 19072357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of weight loss on nonalcoholic fatty liver disease.
    Patel AA; Torres DM; Harrison SA
    J Clin Gastroenterol; 2009; 43(10):970-4. PubMed ID: 19727004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of weight loss on nonalcoholic fatty liver disease.
    Rafiq N; Younossi ZM
    Semin Liver Dis; 2008 Nov; 28(4):427-33. PubMed ID: 18956298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity and physical activity.
    Jakicic JM; Davis KK
    Psychiatr Clin North Am; 2011 Dec; 34(4):829-40. PubMed ID: 22098807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The comparative and cumulative effects of a dietary restriction and exercise on weight loss.
    Dunn CL; Hannan PJ; Jeffery RW; Sherwood NE; Pronk NP; Boyle R
    Int J Obes (Lond); 2006 Jan; 30(1):112-21. PubMed ID: 16231038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weight loss as a treatment for nonalcoholic fatty liver disease.
    Clark JM
    J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S39-43. PubMed ID: 16540766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of changes on body weight and lifestyle in nonalcoholic fatty liver disease.
    Suzuki A; Lindor K; St Saver J; Lymp J; Mendes F; Muto A; Okada T; Angulo P
    J Hepatol; 2005 Dec; 43(6):1060-6. PubMed ID: 16140415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavior therapy for nonalcoholic fatty liver disease: The need for a multidisciplinary approach.
    Bellentani S; Dalle Grave R; Suppini A; Marchesini G;
    Hepatology; 2008 Feb; 47(2):746-54. PubMed ID: 18098321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Non-alcoholic fatty liver disease in children: a new complication of obesity].
    Bocca G; Stolk RP; Scheenstra R; Sauer PJ
    Ned Tijdschr Geneeskd; 2008 Nov; 152(45):2443-7. PubMed ID: 19051794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The trials and tribulations of the treatment of nonalcoholic fatty-liver disease.
    Gan SK; Adams LA; Watts GF
    Curr Opin Lipidol; 2008 Dec; 19(6):592-9. PubMed ID: 18957882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical activity, body weight, and adiposity: an epidemiologic perspective.
    DiPietro L
    Exerc Sport Sci Rev; 1995; 23():275-303. PubMed ID: 7556354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of cardiorespiratory fitness, body mass index, and waist circumference to nonalcoholic fatty liver disease.
    Church TS; Kuk JL; Ross R; Priest EL; Biltoft E; Blair SN
    Gastroenterology; 2006 Jun; 130(7):2023-30. PubMed ID: 16762625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physical activity in the management of obesity.
    Hills AP; Byrne NM
    Clin Dermatol; 2004; 22(4):315-8. PubMed ID: 15475232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exercise and the liver: implications for therapy in fatty liver disorders.
    Johnson NA; Keating SE; George J
    Semin Liver Dis; 2012 Feb; 32(1):65-79. PubMed ID: 22418889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial.
    Harrison SA; Fecht W; Brunt EM; Neuschwander-Tetri BA
    Hepatology; 2009 Jan; 49(1):80-6. PubMed ID: 19053049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Greek adolescents, fitness, fatness, fat intake, activity, and coronary heart disease risk.
    Bouziotas C; Koutedakis Y; Nevill A; Ageli E; Tsigilis N; Nikolaou A; Nakou A
    Arch Dis Child; 2004 Jan; 89(1):41-4. PubMed ID: 14709501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of lifestyle changes in non-alcoholic fatty liver disease.
    Centis E; Marzocchi R; Di Domizio S; Ciaravella MF; Marchesini G
    Dig Dis; 2010; 28(1):267-73. PubMed ID: 20460922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review and meta-analysis of the effect of weight loss on all-cause mortality risk.
    Harrington M; Gibson S; Cottrell RC
    Nutr Res Rev; 2009 Jun; 22(1):93-108. PubMed ID: 19555520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.